GHRP-6 is a growth hormone secretagogue hexapeptide used in controlled in-vitro studies of ghrelin/secretagogue receptor (GHSR-1a) signalling, including Gq/PLC/IP3/Ca2+ pathways and downstream assay readouts under non-clinical laboratory conditions.
GHRP-6
This cyclic amide hexapeptide (sequence: His–D-Trp–Ala–Trp–D-Phe–Lys-NH2) is commonly selected to explore receptor engagement, second-messenger dynamics, and structure–activity relationships within the GH axis in model systems.
For laboratory research only. Not for human use.
GHRP-6 Key features
- Growth hormone secretagogue for in-vitro GHSR-1a receptor pharmacology studies.
- Supplied as a lyophilised solid for stability and straightforward storage.
- Unit size: 10 mg per vial.
- Each batch released only after stringent quality checks
Specifications
- Product name: GHRP-6
- Synonyms: Growth Hormone Releasing Peptide-6; GHSR agonist
- Sequence (one-letter): H–D-W–A–W–D-F–K–NH2
- Class: Hexapeptide secretagogue (ghrelin/secretagogue receptor agonist)
- Form: Lyophilised powder
- Appearance: White to off-white solid
- Note: Salt/counter-ion and hydration state may vary.
Handling & storage
- Storage (dry): Keep vials protected from light and moisture.
- Reconstitution: Bring vial and diluent to room temperature. Reconstitute with
Bacteriostatic Water 10 ml. Swirl gently — do not vortex. - After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
- Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.
Looking for complementary materials? See
Bacteriostatic Water 10 ml and GH-axis research companions such as
CJC-1295 5 mg and
Ipamorelin 5 mg.
About GHRP-6 in research
Researchers use GHRP-6 to probe GHSR-1a receptor engagement, map second-messenger responses (e.g., PLC/IP3/Ca2+), and characterise structure–activity relationships in cell-based assays. These studies focus on receptor pharmacology and pathway modelling exclusively in controlled, non-clinical in-vitro environments.
Synthesis & quality
Manufactured via controlled, validated peptide-synthesis processes to deliver high purity and lot-to-lot consistency. Each batch undergoes identity, purity, and appearance checks before release.
Reviews
There are no reviews yet.